Vericel Corp

Manufacturing · Biological Products, (No Diagnostic Substances)

完成交易日收盘US$41.09+1.43%行情日期 2026-11-03 · 非实时

公开资料页汇总Vericel Corp（VCEL）的已发布行情、估值、风险、财务摘要与同业对比。行情截至2026-11-03，非实时；缺失值不按零处理。

股价走势

复权收盘价（美元）

2025-10-31 — 2026-11-03253 个交易日样本

查看交易日数据

2026-11-03VCELUS$41.09

查看图表数据

日期	VCEL
2025-10-31	35.06
2025-11-03	36.71
2025-11-04	36.25
2025-11-05	37.2
2025-11-06	38.75
2025-11-07	38.94
2025-11-10	38.99
2025-11-11	41.05
2025-11-12	40.44
2025-11-13	39.84
2025-11-14	39.86
2025-11-17	39.43
2025-11-18	39.03
2025-11-19	38.95
2025-11-20	37.85
2025-11-21	39.58
2025-11-24	38.88
2025-11-25	42.54
2025-11-26	40.37
2025-11-28	40.25
2025-12-01	38.82
2025-12-02	37.65
2025-12-03	37.39
2025-12-04	36.79
2025-12-05	36.23
2025-12-08	37.3
2025-12-09	38.38
2025-12-10	37.64
2025-12-11	37.39
2025-12-12	36.54
2025-12-15	36.49
2025-12-16	35.5
2025-12-17	36.4
2025-12-18	36.16
2025-12-19	36.05
2025-12-22	37.37
2025-12-23	37.38
2025-12-24	37.56
2025-12-26	37.66
2025-12-29	37.59
2025-12-30	36.73
2025-12-31	36.01
2026-01-02	35.61
2026-01-05	37.08
2026-01-06	39.34
2026-01-07	40.35
2026-01-08	40.73
2026-01-09	38.56
2026-01-12	36.59
2026-01-13	37.05
2026-01-14	37.33
2026-01-15	38.57
2026-01-16	37.4
2026-01-20	36.29
2026-01-21	37.72
2026-01-22	39.14
2026-01-23	37.85
2026-01-26	37.7
2026-01-27	36.58
2026-01-28	36.2
2026-01-29	36.5
2026-01-30	35.98
2026-02-02	36.94
2026-02-03	37.1
2026-02-04	36.88
2026-02-05	35.38
2026-02-06	36.19
2026-02-09	35.44
2026-02-10	35.59
2026-02-11	34.63
2026-02-12	33.97
2026-02-13	35.96
2026-02-17	36.82
2026-02-18	37.41
2026-02-19	38.17
2026-02-20	38.09
2026-02-23	38.25
2026-02-24	38.25
2026-02-25	37.09
2026-02-26	37.68
2026-02-27	35.68
2026-03-02	35.36
2026-03-03	34.39
2026-03-04	34.96
2026-03-05	34
2026-03-06	33.71
2026-03-09	34.12
2026-03-10	33.4
2026-03-11	32.88
2026-03-12	32.11
2026-03-13	32.54
2026-03-16	32.29
2026-03-17	32.5
2026-03-18	32.3
2026-03-19	32.74
2026-03-20	31.41
2026-03-23	32.45
2026-03-24	33.08
2026-03-25	31.44
2026-03-26	30.82
2026-03-27	29.34
2026-03-30	30.55
2026-03-31	32.17
2026-04-01	32.56
2026-04-02	34.14
2026-04-06	34.08
2026-04-07	33.33
2026-04-08	34.03
2026-04-09	33.59
2026-04-10	33.7
2026-04-13	34.44
2026-04-14	35.14
2026-04-15	35.37
2026-04-16	33.77
2026-04-17	35.68
2026-04-20	35.81
2026-04-21	33.67
2026-04-22	34.37
2026-04-23	34.4
2026-04-24	35.64
2026-04-27	36.92
2026-04-28	35.65
2026-04-29	33.43
2026-04-30	34.73
2026-05-01	35.57
2026-05-04	36.49
2026-05-05	36.81
2026-05-06	36.78
2026-05-07	35.13
2026-05-08	33.46
2026-05-11	32.92
2026-05-12	32.94
2026-05-13	32.84
2026-05-14	33.14
2026-05-15	33.03
2026-05-18	34.87
2026-05-19	34.49
2026-05-20	35.4
2026-05-21	35.15
2026-05-22	34.73
2026-05-26	34.97
2026-05-27	34.27
2026-05-28	34.24
2026-05-29	33.33
2026-06-01	32.82
2026-06-02	34.45
2026-06-03	34.74
2026-06-04	35.69
2026-06-05	36.3
2026-06-08	35.77
2026-06-09	37.03
2026-06-10	37.38
2026-06-11	38.57
2026-06-12	37.46
2026-06-15	38.29
2026-06-16	38.46
2026-06-17	39.13
2026-06-18	40.1
2026-06-22	40.47
2026-06-23	40.39
2026-06-24	41.69
2026-06-25	42.9
2026-06-26	46.23
2026-06-29	45.07
2026-06-30	44.49
2026-07-01	45.15
2026-07-02	46.98
2026-07-06	46.56
2026-07-07	46.95
2026-07-08	47.02
2026-07-09	48.31
2026-07-10	47
2026-07-13	47.49
2026-07-14	46.09
2026-07-15	46.72
2026-07-16	47.81
2026-07-17	46.64
2026-07-20	45.88
2026-07-21	46.14
2026-07-22	44.56
2026-07-23	45.05
2026-07-24	45.05
2026-07-27	45.32
2026-07-28	46.71
2026-07-29	46.62
2026-07-30	47.61
2026-07-31	45.96
2026-08-03	46.05
2026-08-04	46.34
2026-08-05	45.36
2026-08-06	44.75
2026-08-07	45.09
2026-08-10	43.95
2026-08-11	44.35
2026-08-12	44.73
2026-08-13	44.54
2026-08-14	44.2
2026-08-17	43.59
2026-08-18	44.26
2026-08-19	43.57
2026-08-20	42.11
2026-08-21	42.68
2026-08-24	42.3
2026-08-25	43.22
2026-08-26	42.44
2026-08-27	41.18
2026-08-28	40.95
2026-08-31	39.9
2026-09-01	40.5
2026-09-02	40.89
2026-09-03	40.47
2026-09-04	40.19
2026-09-08	39.08
2026-09-09	38.99
2026-09-10	37.87
2026-09-11	38.34
2026-09-14	39.6
2026-09-15	39.72
2026-09-16	40.21
2026-09-17	40.03
2026-09-18	40.02
2026-09-21	39.55
2026-09-22	40.22
2026-09-23	38.79
2026-09-24	39.3
2026-09-25	39.71
2026-09-28	40.24
2026-09-29	40.61
2026-09-30	40.14
2026-10-01	39.44
2026-10-02	40.15
2026-10-05	41.07
2026-10-06	40.05
2026-10-07	40.74
2026-10-08	40.05
2026-10-09	40.1
2026-10-12	40.62
2026-10-13	40.3
2026-10-14	40.25
2026-10-15	41.02
2026-10-16	40.13
2026-10-19	40.37
2026-10-20	40.58
2026-10-21	40.94
2026-10-22	42.97
2026-10-23	42.53
2026-10-26	43.04
2026-10-27	43.27
2026-10-28	41.09
2026-10-29	42.91
2026-10-30	40.26
2026-11-02	40.51
2026-11-03	41.09

1、3、6、12个月分别按21、63、126、252个交易日取区间；缺失日期不从区间外补齐。

使用已有每日复权收盘样本，非实时行情；图中价格可能与未复权收盘报价不同。

01 · MARKET FRAME

行情、估值与风险

基于已完成交易日和已发布财务资料

市值US$2.1B

市盈率（TTM）86.9×

自由现金流收益率+1.2%

距52周高点-14.9%

近一年波动率+41.2%

近一年最大回撤-31%

区间涨跌幅

10日+1.3%起点 2026-10-20

30日+2.2%起点 2026-09-22

90日-11.1%起点 2026-06-26

180日+11.6%起点 2026-02-17

250日+13.4%起点 2025-11-04

区间涨跌幅使用复权收盘价；估值和风险指标缺失时显示为—，不按零处理。

02 · FINANCIAL TRACE

财务摘要

公开页仅显示最近3个已校验报告期

年度财务走势

百万美元 · 年度报告期

查看报告期数据

2025-12-31营收276.3百万美元

指标	2026-07-24	2026-06-30	2025-12-31	2025-07-24	2025-06-30	2024-12-31	2024-07-24	2024-06-30	2023-12-31
营收	—	—	276.3	—	—	237.2	—	—	197.5
净利润	—	—	16.5	—	—	10.4	—	—	-3.2
自由现金流	—	—	24.7	—	—	-5.8	—	—	15.3
股份数	51.2	—	—	50.5	—	—	49	—	—
债务	—	—	—	—	—	—	—	—	—
总资产	—	502.9	—	—	435.6	—	—	376.8	—

客户合同口径 · 营收采用客户合同口径，可能不等同于公司全部收入。

金额及股份数均以百万为单位。缺失或待核验数据不按零处理。

03 · PEER SET

同业对比

同一细分行业中市值最接近的公司

公司	市值	近250日涨跌幅	市盈率	距52周高点	波动率
BCRX百奥克里斯特制药	US$2.2B	+26.8%	—	-22.9%	+48.1%
COAGHemab Therapeutics Holdings, Inc.	US$2B	—	—	—	—
REPL瑞普利缪恩	US$2B	+130.2%	—	+6%	+187.1%
VIR维尔生物技术	US$1.9B	+113.7%	—	-6%	+64.1%

同业由已覆盖公司的行业分类和市值接近度确定，仅用于横向研究；缺失数据不按零处理。